MedCath Corporation to Hold Conference Call on Fourth Quarter Results

Friday, November 2, 2007 General News J E 4
CHARLOTTE, N.C., Nov. 1 MedCath Corporation(Nasdaq: MDTH) will host a conference call Wednesday, November 14, at 9 a.m.Eastern Time to discuss results from its fourth quarter ended September 30,2007. The company will issue a press release announcing those results priorto the earnings call.

The conference call will be archived and accessible by dialing(800) 642-1687 (domestic callers) or (706) 645-9291 (international callers).The archived conference ID is 22236624. The call will be accessible until11:59 p.m. ET on November 20, 2007. It also will be available on thecompany's web site ( on or immediately following November 14for 30 days.

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcareprovider focused primarily on the diagnosis and treatment of cardiovasculardisease. MedCath focuses on serving the unique needs of patients sufferingfrom cardiovascular disease. MedCath owns interests in and operates elevenhospitals with a total of 667 licensed beds, located in Arizona, Arkansas,California, Louisiana, New Mexico, Ohio, South Dakota, and Texas. Inaddition, MedCath manages the cardiovascular program at various hospitalsoperated by other parties. Further, MedCath provides cardiovascular careservices in diagnostic and therapeutic facilities located in various states.What: Fourth Quarter Earnings Conference Call When: 9:00 a.m. ET, Wednesday, November 14, 2007 How: Dial-in conference call (877) 697-5351 (domestic callers), (706) 634-0602 (international callers) Conference ID: 22236624 Live web cast at Contacts: O. Edwin French, President & CEO James Harris, CFO

SOURCE MedCath Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
ArthroCare Launches New, Intelligent Controller an...
Abbott Researchers Target Neuronal Nicotinic Recep...